China will strengthen the monitoring of adverse reactions of traditional Chinese medicine injections

It was learned from the State Food and Drug Administration on April 15 that this year, the Bureau will fully implement the standard improvement of Chinese medicine injections, carry out appraisal sampling examinations for Chinese medicine injections in batches, strengthen the monitoring of adverse reactions to TCM injections, and Conduct a comprehensive evaluation.

The bureau requested that the drug regulatory departments of all provinces (autonomous regions and municipalities) should continue to organize the investigation of the risk of production and quality control of traditional Chinese medicine injection companies in their jurisdictions to effectively control the safety risks of traditional Chinese medicine injections; it is necessary to make Shuanghuanglian injections and other related products. The comprehensive evaluation work guides the production enterprises to carry out research on the safety reevaluation of TCM injections.